| Zaal Kristien J. | Sirt1 Deficient Mice Exhibit An Altered Cartilage Phenotype. |
| Zacharisen Michael | Children with Ehlers-Danlos Syndrome and Airway Dysfunction. |
| Zack Debra J. | Factors Associated with Relapse of Remission in Rheumatoid Arthritis. |
| | Is Long-Term Etanercept Monotherapy Ever An Option in a Patient with Moderate to Severe Rheumatoid Arthritis (RA)? |
| Zadeh Armin | Non-Calcified Coronary Plaque in Systemic Lupus Erythematosus Quantitative Analysis. |
| Zaenker Michael | Diastolic Heart Failure in Rheumatoid Arthritis Correlates with Reduction in Global Longitudinal Strain and Occurs Independent From Therapy with Tumor Necrosis Factor Inhibitors. A Study with Tissue Doppler, Strain Imaging, and NTproBNP Measurement. |
| Zafar Sara | Increased Awareness of Arthritis May Result in Earlier Diagnosis of Rheumatoid Arthritis. |
| Zahr Zaki Abou | Predictors of Corticosteroid Tapering in Systemic Lupus Erythematosus Patients. |
| Zakem Jerald M. | Circulating T Helper Cells in Patients with Systemic Lupus Erythematosus Share the Phenotypic Property with Lymphoid T Follicular Helper Cells. |
| | Fibromyalgia: Can Online Cognitive Behavioral Therapy Help? |
| Zalewski Christopher | Predictors of Organ Damage Despite Serologic Remission in a Subset of Patients with Neonatal-Onset Multisystem Inflammatory Disease (NOMID). |
| Zamani O. | Golimumab Use and Sustained Clinical Response in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-Tumor Necrosis Factor Alpha Agents. |
| | Safety Profile of Belimumab, a B-Lymphocyte StimulatorSpecific Inhibitor, in Phase 2 and 3 Clinical Trials of Patients with Active Systemic Lupus Erythematosus. |
| | Comparing 2 Referral Strategies to Diagnose Axial Spondyloarthritis: The Recognizing and Diagnosing Ankylosing Spondylitis Reliably Study. |
| Zamanian Roham T. | Functional Class Change in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Associations with Survival and Exercise Capacity. |
| Zambrowicz Brian | The Oral S1P Lyase Inhibitor LX3305 (LX2931) Demonstrates Favorable Safety and Potential Clinical Benefit at 12-Weeks in a Phase 2 Proof-of-Concept Trial in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Therapy. |
| Zamecnik Josef | Visfatin and B-Cell Activating Factor of the TNF Family Serum Levels Correlate with Disease Activity in Anti-Jo-1 Positive Patients with Idiopathic Inflammatory Myopathies. |
| Zampeli E. | Myocardial Ischemia in Asymptomatic Patients with Rheumatoid Arthritis: A Comparative Study with Diabetes Mellitus. |
| | Rate of Progression of Subclinical Atherosclerosis in Femoral Versus Carotid Arteries in Patients with Rheumatoid Arthritis Over 3 Years. |
| Zampogna Giuseppe | High-Dose I.v. N-Acetylcysteine Increases Peripheral Tissue Perfusion and Improves Clinical Symptoms of Systemic Sclerosis Patients. A Pilot Study. |
| | Progression of Microvascular Damage Through Different Nailfold Capillaroscopic Patterns in Systemic Sclerosis Patients. |
| Zan Moe T. | Increased Frequency of Complement C4B Deficiency in Rheumatoid Arthritis (RA): Interaction with the Shared Epitope (SE). |
| Zanchetta J. R. | Denosumab Decreases Cortical Porosity in Postmenopausal Women with Low Bone Mineral Density. |
| Zandonade E. | Quality of Life and Psychosocial Aspects Among School Adolescents with Diffuse Chronic Musculoskeletal Pain in Brazil. |
| Zang Yunjuan | Role of MyD88-Dependent Toll-Like Receptor Signaling in a Murine Model of Histidyl-tRNA Synthetase-Induced Myositis. |
| Zappia Brian | Distinct Functional Activation and Connectivity Patterns for a Visuo-Constructional Task in Childhood-Onset Systemic Lupus Erythematosus and Matched Controls. |
| Zarabadi S. Alireza | A Safety Analysis of Oral Prednisone As a Pre-Treatment for Rituximab in Rheumatoid Arthritis. |
| Zarco Pedro | Correlation Biomarkers of Cartilage and Bone Turnover with Disease Activity, Function, Quality of Life, Radiology and Magnetic Resonance Imaging in Patients with Early Spondiloarthritis. |
| Zarnitsky Charles | Anti-TNF Efficacy Against Spondyloarthropathy without Associated Imaging Signs. |
| Zarro Vincent | Sonographic Detection of a Bifid Median Nerve and Persistent Median Artery Among Patients with Clinical Diagnosis of Carpal Tunnel Syndrome in Rheumatology Office. |
| Zauner Dorothea | Sonoelastography Detects Rigidity of Salivary Glands in Primary Sjgren's Syndrome. |
| Zavaleta-Muniz Soraya | R577X Alpha-Actinin 3 ACTN3) polymorphism Is Associated with Inflammatory Myopathies in Mexican population. |
| Zayed Nadia | Early Growth Response factor1 Mediates the Suppressive Effect of Interleukin-1 on Peroxisome proliferatoractivated Receptor Gamma Expression in Human Osteoarthritic Chondrocytes. |
| Zbehlik Alicia J. | A Clinical Microsystem Analysis of An Academic Rheumatology Practice Is High-Yield for Identifying Improvement Opportunities. |
| Zebaze R. M. | Denosumab Decreases Cortical Porosity in Postmenopausal Women with Low Bone Mineral Density. |
| Zechner Peter | Ultrasound Screening for Intestinal Lung Disease in Rheumatoid Arthritis. |
| Zeft Andrew S. | Major Histocompatibility Complex Class II Gene Cluster Harbors Systemic Juvenile Idiopathic Arthritis Susceptibility Locus. |
| | Parent and Patient Treatment Preferences in Juvenile Idiopathic Arthritis. |
| | Trial of Early Aggressive Therapy in Polyarticular Juvenile Idiopathic Arthritis. |
| Zeggini Eleftheria | Major Histocompatibility Complex Class II Gene Cluster Harbors Systemic Juvenile Idiopathic Arthritis Susceptibility Locus. |
| Zeh Gunther | Early Response to Tocilizumab in Patients with Treatment Resistant Rheumatoid ArthritisAssessment Using 3 Tesla MRI. |
| Zeidler Henning | Baseline Radiographic Damage, Elevated Acute Phase Reactants and Cigarette Smoking Status Predict Radiographic Progression in the Spine in Early Axial Spondyloarthritis. |
| | Non-Steroidal Anti-Inflammatory Drugs Reduce Radiographic Spinal Progression in Patients with Ankylosing Spondylitis but Not in Non-Radiographic Axial Spondyloarthritis. |
| Zejden Anna | Anterior Chest Wall Inflammation by Whole Body MRI in Patients with Spondyloarthritis: Lack of Association Between Clinical and Imaging Findings. |
| Zekharya Tomer | Genetic Variations within the CD6 and Syntaxin Binding Protein 6 Genes Associated with Response to Tumor Necrosis Factor Alpha Inhibitors in Danish Patients with Rheumatoid Arthritis Treated in Routine Care. |
| Zekraoui Leila | Late Apoptotic Bodies Mediates Sterile Inflammation in Vitro and In Vivo Via IL-1alpha. |
| Zelenika Diana | Family-Based Association Study of SPA3, a New Susceptibility Locus for Spondyloarthritis on 6p11-q11. |
| Zelko Frank | Brain Morphometric Changes Associated with Childhood-Onset Systemic Lupus Erythematosus and Neurocognitive Deficit. |
| | Behavior, Executive and Perceived Neuropsychological Functioning with Childhood-Onset Systemic Lupus ErythematosusResults of a Best-Friend Controlled Study. |
| | Distinct Functional Activation and Connectivity Patterns for a Visuo-Constructional Task in Childhood-Onset Systemic Lupus Erythematosus and Matched Controls. |
| Zell Joann | Effect of Health Insurance Coverage on Quality of Care in SLE. |
| | Increased Disease Activity Measure in Systemic Lupus Erythematosus Is Adversely Associated with Pregnancy and Pregnancy Outcomes. |
| Zemel Lawrence S. | Shrinking Lung Syndrome is a Multifactorial Process Featuring Reduced Lung Compliance and Extrinsic Ventilatory Restriction. |
| Zemmour Christophe | Colony Stimulating Factor 1 Receptor Inhibition Has Anti-Inflammatory and Potent Early Onset Bone and Cartilage Protective Effects. |
| Zeng Qinghua | Transforming Growth Factor- Receptor One Variant Is Associated with Constitutively Decreased Transforming Growth Factor- Signaling and Risk for Systemic Sclerosis. |
| Zeng Xiaofeng | Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry: Prevalence and Risk Factors of Pulmonary Arterial Hypertension and Interstitial Lung Disease in Chinese Patients with Systemic Lupus Erythematosus. |
| Zerbe Gary O. | The Association Between Rheumatoid Factor and Predisposing Factors for Atherogenesis in First-Degree Relatives without Rheumatoid Arthritis: Studies of the Etiology of Rheumatoid Arthritis. |
| Zerbini C A. F. | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, in Combination with Methotrexate, in Patients with Active Rheumatoid Arthritis with An Inadequate Response to Tumor Necrosis Factor-Inhibitors: A 6-Month Phase 3 Study. |
| | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: a 24-Month Phase 3 Study. |
| Zerr Pawel | Heart Involvement in Patients with Systemic Sclerosis Is Mimicked by Fra-2 Transgenic Mice. |
| | Platelet Derived Growth Factor Receptor Inhibitor ARRY-768 Prevents Experimental Dermal Fibrosis and Induces Regression of Pre-Established Dermal Fibrosis. |
| | JAK2 Mediates the Stimulatory Effects of Transforming Growth Factor beta on Fibroblast Activation and Tissue Fibrosis. |
| | Transforming Growth Factor Beta Mediated Activation of Canonical Wnt Signaling Is Crucial for the Development of Fibrosis In Systemic Sclerosis. |
| | Tribbles Homolog 3 Mediates Transforming Growth Factor Beta Driven Dermal Fibrosis In Systemic Sclerosis. |
| | Inhibition of Glycogen Synthase Kinase 3 Induces Dermal Fibrosis by Activation of the Canonical Wnt Pathway. |
| | The Nuclear Receptor CAR Mediates the Pro-Fibrotic Effects of TGF- and Contributes to the Development of Experimental Dermal Fibrosis. |
| Zhang Bin | Developmental Trajectories of WOMAC Knee Pain and Their Predictors Over 3 Years Among Subjects of Osteoarthritis Initiative. |
| | Using A Novel Approach to Estimate Effects of Depression On Changes In Knee Pain Severity In Osteoarthritis Initiative. |
| | Patterns of WOMAC Function in People with or At High Risk of Knee Osteoarthritis: The Osteoarthritis Initiative. |
| Zhang Chun-Mei | Microarray Gene Expression Profiling of Articular Chondrocyte In Patients with Osteoarthritis. |
| Zhang Florence Q. | Binding of Serum IgG to Human Mesangial Cells and Its Correlation with Disease Activity in Patients with Lupus Nephritis. |
| Zhang Frank | Prevalence of Autoimmune Diseases and Other Comorbidities in Patients with Psoriatic Arthritis in the United States. |
| | Economic Burden of Psoriatic Arthritis and Diabetes in Patients with Psoriatic Arthritis in the United States. |
| | Economic Burden of Psoriatic Arthritis and Obesity in Patients with Psoriatic Arthritis in the United States. |
| Zhang Hong | Modeling Human Rheumatoid Arthritis In Non-Human Primate: Type II Collagen Induced Arthritis In Cynomolgus Macaques. |
| | Impact of Psychosocial Determinants on Total Knee Replacement Costs: Results From the Patient Expectations about Knee Surgery Cohort. |
| | Impact of Slow Recovery and Poor Functional Outcomes on Direct and Indirect Costs After Total Knee Replacement in Osteoarthritis Patients. |
| | The Effect of Physician Communication on Treatment Adherence in Patients with Rheumatoid Arthritis. |
| Zhang Huayong | Allogeneic Mesenchymal Stem Cells Transplantation in Severe and Refractory Systemic Lupus Erythematosus-Four Years Follow up. |
| Zhang Jie | Use of Pharmacologic Agents for the Prevention of Osteoporosis Among Older Women with Low Bone Mass Is Discordant with National Osteoporosis Foundation Guidance. |
| | Risk for Herpes Zoster in Patients with Rheumatoid and Psoriatic Arthritis. |
| | Safety of Zoster Vaccine in Individuals with Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Disease. |
| Zhang Jiyun | Activated NF-Kb in Mesenchymal Cells From SLE Patients Inhibits Osteogenic Differentiation Through Down-Regulating Smad Signaling. |
| Zhang Jun | The Burden of Autoimmunity and Risk for Coronary Artery Disease in Rheumatoid Arthritis. |
| Zhang Junmei | Clinical and Immunological Effects of Etanercept on Juvenile Idiopathic Arthritis in China. |
| Zhang Kui | Transforming Growth Factor- Receptor One Variant Is Associated with Constitutively Decreased Transforming Growth Factor- Signaling and Risk for Systemic Sclerosis. |
| Zhang L.Q. | Decreased Expression of Nicotinamide Phosphoribosyltransferase (NAMPT) in Active Juvenile Idiopathic Arthritis Patients Receiving Methotrexate. |
| Zhang Lening | Cognitive Differences in Systemic Lupus Erythematosus Patients From the Western (Denver, CO) and Eastern (New York, NY) Regions of the United States. |
| Zhang Li | Microarray Analysis of the autologous Hematopoietic Stem Cell Transplantation Induced Remission Associated CD8 Treg Cells Gene Expression Profile. |
| | Peptides Inducing Potent Autoantigen-Specific Treg Cells in Human Lupus. |
| Zhang Miaojia | High Expression of Haptoglobin in the Peripheral Blood Mononuclear Cells From Methotrexate-Resistant Rheuamatoid Arthritis Patients. |
| Zhang Peng | Inhibited Expression of HPK1 Associated with Loss of JMJD3 Promoter Binding Contributes to Autoimmunity in Systemic Lupus Erythematosus. |
| Zhang Qing | Inhibited Expression of HPK1 Associated with Loss of JMJD3 Promoter Binding Contributes to Autoimmunity in Systemic Lupus Erythematosus. |
| Zhang Ray | A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BIIB023 (Anti-TWEAK) in Subjects with Rheumatoid Arthritis. |
| Zhang Ruoxin | The Impact of An Evidence-Based Community-Delivered Exercise Program on Arthritis Symptoms and Health-Related Quality of Life. |
| Zhang Shuyu | A Randomized, Double-Blind Comparison of Duloxetine 30 Mg Once Daily (QD) and Placebo in Adult Patients with Fibromyalgia. |
| Zhang Weihan | A Novel, Highly Selective Syk Kinase Inhibitor Significantly Ameliorates the Severity of Arthritis in Rodents. |
| Zhang Xian | Effects of Altering Fli1 Levels in Lupus T Cells on Disease Expression and T Cell Function in the MRL/Lpr Mouse Model. |
| | Interferon Regulatory Factor-4 deficient Lupus-Prone MRL/LprMice Show Strong Propensity for Th1 Polarity and Develop Granulomatous Lesions in Multiple Organs. |
| | Role of Transcription Factor Fli-1 in Regulation of Dendritic Cell and Monocyte Development. |
| Zhang Xiao | The Efficacy and Mechanism of Bisphosphonate on Glucocorticosteroid-Induced Osteoporosis in Systemic Lupus Erythematosus Patients. |
| Zhang Xin | Circulating T Helper Cells in Patients with Systemic Lupus Erythematosus Share the Phenotypic Property with Lymphoid T Follicular Helper Cells. |
| Zhang Xuewu | Effects of Technetium-99 Conjugated with Methylene Diphosphonate on Rats with Glucocorticoid Induced Osteoporosis. |
| | Safety of Infliximab Therapy in Rheumatoid Arthritis Patients with Pre-Existing Hepatitis B Virus Infection. |
| Zhang Ying | Medication Impact on Gene Expression Patterns May Depend on Biologic Subgroups in the Biomarkers of Lupus Disease (BOLD) Study. |
| Zhang Yunhui | Varus Thrust and Knee Frontal Plane Dynamic Motion in Persons with Knee Osteoarthritis. |
| | Sagittal Plane Hip Motion During Gait and Function and Disability in Knee Osteoarthritis. |
| | Muscle Parameters and Function Self-Efficacy in Knee Osteoarthritis. |
| | Relationship Between Aspects of the Pain Experience in Knee Osteoarthritis and Function and Disability. |
| Zhang Yuqing | Recent Heavy Physical Activities Trigger Knee Pain Exacerbation in Persons with Symptomatic Knee Osteoarthritis. |
| | Functional Impairment As a Predictor of Knee Replacement in the Multicenter Osteoarthritis Study. |
| | Relation of Knee Cartilage Loss to Pain and Functional Limitation: The Multicenter Osteoarthritis Study. |
| | Is Knee Pain Relevant for Meeting Physical Activity Guidelines Among People with Knee Osteoarthritis Who Can Walk Already Walk At a Moderate Intensity? the Multicenter Osteoarthritis Study. |
| | Patterns of WOMAC Function in People with or At High Risk of Knee Osteoarthritis: The Osteoarthritis Initiative. |
| | Allopurinol Initiation and the Risk of Death in the General Population. |
| | Co-Localization of Non-Cartilaginous Articular Pathology and Cartilage Damage in Regard to Subsequent Cartilage Loss in Subjects with or at Risk for Knee Osteoarthritis - the MOST Study. |
| | Pressure Pain Threshold and Knee Pain in Osteoarthritis: The Multicenter Osteoarthritis Study. |
| | Incidence of Peripheral Vascular Disease and Myocardial Infarction Among Patients with Giant Cell Arteritis. |
| | Incidence of Cerebrovascular Accidents Among Patients with Giant Cell Arteritis. |
| | Giant Cell Arteritis Is Associated with An Increase in Both All-Cause and Cardiovascular Mortality. |
| | Giant Cell Arteritis Is Associated with Incident Coronary Heart Disease-A Population-Based Study. |
| | Is 10,000 Steps Enough to Meet Physical Activity Guidelines?: The Multicenter Osteoarthritis Study. |
| | Using A Novel Approach to Estimate Effects of Depression On Changes In Knee Pain Severity In Osteoarthritis Initiative. |
| | Developmental Trajectories of WOMAC Knee Pain and Their Predictors Over 3 Years Among Subjects of Osteoarthritis Initiative. |
| | Obesity and the Risk of Psoriatic Arthritis in the General Population. |
| | Hypothyroidism and Risk of Adhesive Capsulitis in the General Population. |
| | Long-Term Warfarin Use Is Not Associated with Fracture Risk. |
| | Cartilage Damage in the Tibio-Femoral and Patello-Femoral Joints and Risk of Progression: Role of Prevalent Damage Severity the MOST Study. |
| | Obesity Increases the Risk of Adhesive Capsulitis. |
| | The Association of Symptomatic Osteoarthritis At Multiple Time Points with Functional Limitation Over 5 Years: The Multicenter Osteoarthritis Study. |
| | Time-Course and Extent of Pain and Function Improvements Post-Knee Replacement: The Multicenter Osteoarthritis Study. |
| | Does Physical Performance Mediate the Effect of Knee Osteoarthritis and Risk of Indoor and Outdoor Falls in Older Men and Women? |
| | Short Periods of Glucocorticoid Use Are Associated with a Prolonged Risk of Osteonecrosis. |
| | Risk Factors for Incident Psuedogout in the General Population. |
| Zhang Zhe | Genome-Wide Analyses of IRF1 and H4 Acetylation in SLE Monocytes. |
| Zhang ZhuoLi | The Baseline Characteristics and Survival of Chinese Patients with Connective Tissue Disease Associated Pulmonary Arterial Hypertension. |
| Zhao Haoran | A Novel, Highly Selective Syk Kinase Inhibitor Significantly Ameliorates the Severity of Arthritis in Rodents. |
| | HM-018, An Oral Small Molecule JAK Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis (EAE) in Mice. |
| Zhao Jian | Risk Alleles of SLE Associated IL10 SNPs Conferred Differential Binding to Transcription Factors. |
| | Association of a Functional Variant in TLR7 with Systemic Lupus Erythematosus and Rheumatoid Arthritis in Multiple Ancestries. |
| | SLE-Risk Alleles of SNPs in the NMNAT2/SMG7 Region Are Associated with Lower mRNA Levels of SMG7. |
| Zhao Jing | TL1A Induces the Production of Follicular Helper T Cells in Rheumatoid Arthritis. |
| Zhao Jiuliang | Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry: Prevalence and Risk Factors of Pulmonary Arterial Hypertension and Interstitial Lung Disease in Chinese Patients with Systemic Lupus Erythematosus. |
| Zhao Ming | Inhibited Expression of HPK1 Associated with Loss of JMJD3 Promoter Binding Contributes to Autoimmunity in Systemic Lupus Erythematosus. |
| Zhao Wenpu | Atherosclerosis Biomarkers in Systemic SclerosisA Multiplex Analysis. |
| Zhao Xianling | Activation of AMP-Activated Protein Kinase (AMPK) Alleviates Endoplasmic Reticulum (ER) Stress and Inhibits Catabolic Responses to Biomechanical Injury in Chondrocytes. |
| Zhao Xiaoyan | Development of a High-Throughput, Multiplex Assay for Profiling the Autoantibody Fine Specificity in Rheumatoid Arthritis. |
| | Investigation of a Multi-Biomarker Disease Activity (Vectra DA) Signature and Algorithm Score in Rheumatoid Arthritis Patients with Low Disease Activity: The REMIRA Study. |
| Zhao Sr. Miansong | High Risk of Human Papillomavirus Type 58 Infections and of Cervical Squamous Intraepithelial Lesions in Sjogren 's Syndrome Patients. |
| Zheng Hellen | Modeling Human Rheumatoid Arthritis In Non-Human Primate: Type II Collagen Induced Arthritis In Cynomolgus Macaques. |
| Zheng Jianbiao | Increased T Cell Receptor Clonotype Sharing Among Ankylosing Spondylitis Patients Revealed by Deep Repertoire Sequence Analysis. |
| Zheng John | Progesterone Modulates Interferon-Alpha-Inducible Gene Expression in Human Leukocytes. |
| Zheng Song G. | Human CD8 regulatory T cells generated Ex-Vivo have Potent Protective Activity In Vivo. |
| | All-Trans Retinoic Acid Sustains the Stability and Function of Natural Regulatory T Cells From Human and Patients with SLE. |
| | Gingiva-Derived Mesenchymal Stem Cells-Mediated Therapeutic Intervention for Experimental Arthritis. |
| | Therapeutic Effects of TGF--Induced Regulatory T Cells on the Established Autoimmune Diseases. |
| | Adoptive Transfer of Induced-Regulatory T Cells Effectively Attenuates Murine Airway Allergic Inflammation. |
| | CD4 Cells Generated with TGF- and All-Trans Retinoic Acid From Nave CD4 Cells Isolated From Lupus Mice Suppress Lupus in Mice. |
| | Immune Suppression and Injury Tolerance in Fibrotic Liver Are Mediated by Induced Regulatory T Cells Which Safeguard Fibroplasias From Clearance. |
| Zheng Timothy S. | A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BIIB023 (Anti-TWEAK) in Subjects with Rheumatoid Arthritis. |
| Zhi Lin | Novel Small Molecule Inhibitors of Interleukin-1 Receptor Associated Kinase-4 Are Effective in a Preclinical Model of Arthritis. |
| Zhijie WANG | Relationship of Specific Pain Patterns in Knee Osteoarthritis with Severity of Pain and Functional Disability. |
| Zhijie Zhou | Prognostic and Diagnostic Significance of Autoantibodies to Citrullinated Proteins (ACPA) in Patients with a Scleroderma-Rheumatoid Arthritis (SSc-RA) Overlap Syndrome. |
| Zhong Z. John | Post Hoc British Isles Lupus Assessment Group Index Mucocutaneous Organ Domain Item Analysis of Systemic Lupus Erythematosus Patients Treated in Phase 3 Belimumab Clinical Trials. |
| Zhong Z.J. | Safety Profile of Belimumab, a B-Lymphocyte StimulatorSpecific Inhibitor, in Phase 2 and 3 Clinical Trials of Patients with Active Systemic Lupus Erythematosus. |
| | Sustained Disease Improvement and Safety Profile Over the 1500 Patient-Year Experience (6 years) with Belimumab in Patients with Systemic Lupus Erythematosus. |
| | Clinical and Laboratory Correlates in Responders (by the Systemic Lupus Erythematosus Responder Index) in Phase 3 Belimumab Clinical Trials. |
| | Responders in the Phase 3 Belimumab Clinical Trials in Patients with Systemic Lupus Erythematosus Reported Improvements in Fatigue and Health-Related Quality of Life At Week 52. |
| | Factors Associated with Belimumab Treatment Benefit: Results From Phase 3 Studies in Patients with Systemic Lupus Erythematosus. |
| | Effect of Belimumab Treatment on Renal Outcomes: Results From Phase 3 Belimumab Clinical Trials in Patients with Systemic Lupus Erythematosus. |
| Zhou Bei | A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple, Intravenous, Ascending-Dose Study of Sirukumab in Patients with Cutaneous or Systemic Lupus Erythematosus. |
| Zhou Bi | Increased Frequency of Complement C4B Deficiency in Rheumatoid Arthritis (RA): Interaction with the Shared Epitope (SE). |
| Zhou Hua | Urinary Exosomal Microrna-192 and -195 As Potential Biomarkers of Renal Disease Activity in Lupus Nephritis. |
| | Renal Mir-150 As Potential Biomarker of Chronicity in Lupus Nephritis. |
| Zhou Lan | Characterization of a New Category of Autoinflammatory Disease Associated with Nucleotide Oligomerization Domain2 Gene Mutations: An Expanded Cohort Study. |
| Zhou T. | Low Placebo Responses and Clinical Components of the Biomarkers of Lupus Disease (BOLD) Study May Provide Useful Insights for Systemic Lupus Erythematosus Clinical Trial Design. |
| Zhou Tianhui | Medication Impact on Gene Expression Patterns May Depend on Biologic Subgroups in the Biomarkers of Lupus Disease (BOLD) Study. |
| Zhou Wei | The Baseline Characteristics and Survival of Chinese Patients with Connective Tissue Disease Associated Pulmonary Arterial Hypertension. |
| Zhou Wenxu | Improving Therapy Effect on Arthritic Rats by Co-Expression of CD40LIg and IB. |
| Zhou Xiaodong | Immunochip Genotyping of 1,884 Systemic Sclerosis Cases and 4,325 Controls Reveals Novel Associations. |
| | HLA DQB103:02 Is a Marker for Severity of Interstitial Lung Disease in Systemic Sclerosis. |
| Zhou Xiaoqun | IL-22 Restrains the Progression to Severe Arthritis. |
| Zhou Yifang | Clinical and Immunological Effects of Etanercept on Juvenile Idiopathic Arthritis in China. |
| Zhou Yiying | Golimumab Use and Sustained Clinical Response in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-Tumor Necrosis Factor Alpha Agents. |
| Zhu Jay | Cathepsin S Activity Measurements in Tears As a Putative Marker of Sjgren's Syndrome. |
| Zhu Jiaxin | Effects of Technetium-99 Conjugated with Methylene Diphosphonate on Rats with Glucocorticoid Induced Osteoporosis. |
| Zhu Jing W. | Mice Lacking the Receptor-Like Protein Tyrosine Phosphatase CD148 Are Protected From Bleomycin-Induced Pulmonary Fibrosis. |
| Zhu Tracy Y. | Low Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Associated with Increased Augmentation Index in Patients with Early Rheumatoid Arthritis. |
| | Alterations of Bone Geometry, Volumetric Density and Microarchitecture in Women with Systemic Lupus Erythematosus on Chronic Corticosteroids: A Case-Control Study Using High Resolution-Peripheral Quantitative Computed Tomography. |
| | Disease Damage Has Deleterious Effect on Trabecualr Bone Microarchitecture in Female Patients with Systemic Lupus Erythematosus On Chronic Corticosteroids. |
| | Infliximab Is Associated with Improvement in Arterial Stiffness in Patients with Early Rheumatoid Arthritisa Randomized Trial. |
| Zhu Wei | Identification of Activated Cytokine Pathways in the Blood of Systemic Lupus Erythematosus, Myositis, Rheumatoid Arthritis, and Scleroderma Patients. |
| | Systemic Lupus Erythematosus, Myositis, Rheumatoid Arthritis, and Scleroderma Patients Share Activation of a Common Type I Interferon Pathway. |
| Zhu Xiaoming | High Expression of Haptoglobin in the Peripheral Blood Mononuclear Cells From Methotrexate-Resistant Rheuamatoid Arthritis Patients. |
| Zhu Xiaoxia | Resveratrol Deacetylating Rela/p65 Contributes to Inhibit Transforming Growth Factor-Alpha Induced Inflammation Via a Sirt1 Dependent Manner. |
| Zhu Yanyan | Risk Factors for Incident Psuedogout in the General Population. |
| | Obesity Increases the Risk of Adhesive Capsulitis. |
| | Does Treatment of Asymptomatic Hyperuricemia Improve Cardio and Neurovascular Outcomes? A Decision-Analytic Evaluation. |
| | Allopurinol Initiation and the Risk of Death in the General Population. |
| | Consequences of Knee Buckling: The Multicenter Osteoarthritis Study. |
| | Obesity and the Risk of Psoriatic Arthritis in the General Population. |
| | Hypothyroidism and Risk of Adhesive Capsulitis in the General Population. |
| Zhu Yong | Cell Penetrating Recombinant Foxp3 Protein Enhances Treg Function, Suppresses Th17 Cells and Ameliorate Arthritis. |
| Zhu Zejin | Ocular Complication and Its Association with Disease Characteristics and Treatment Responses in a Cohort of 295 Rheumatoid Arthritis Patients. |
| Zhuang Yingxin | Anti-DNA Antibody Production Is Restricted by the Germline Composition of DH Genes. |
| Zibit Melanie | Designing a Community-Based Intervention to Improve the Health of Medically-Underserved Women with Systemic Lupus Erythematosus. |
| Zickert Agneta | Serum Cytokines in Lupus Nephritis, Levels of IL-17 and IL-23 in Association to Histopathology and Response to Treatment. |
| | Association of STAT4, IRF5 and BLK Polymorphisms with Severity and Outcome in Lupus Nephritis. |
| | Vascular Events and HLA-DRB1 Genotypes in Systemic Lupus Erythematosus. |
| Ziegler Julie T. | Fine Mapping of Xq28: Both MECP2/IRAK1 and NAA10/RENBP Contribute to Risk for SLE in Multiple Ancestral Groups. |
| | Lupus Nephritis Susceptibility Markers in PDGRFA-GSX2, SLC5A11, ID4, and HAS2-SNTB1 Regions Identified From a Meta-Analysis of Genome Wide Association Studies of Women with Systemic Lupus Erythematosus. |
| Zielinski Carolyn | Downregulation of Mcl-1 by Ursolic Acid, a Pentacyclic Triterpenoid, Sensitizes Rheumatoid Arthritis Synovial Fibroblasts for TRAIL-Induced Apoptosis. |
| Zierler Brenda | Clinical Decision Support System Improves Bone Mineral Density Screening Rates in 65 Year Old Women. |
| Ziglioli Tamara | Predictors, Features and Effects of First Biologic Switch in Rheumatoid Arthritis within GISEA register: Italian 10-Year Experience. |
| | Systemic Vasculitis and Pregnancy: Maternal and Neonatal Outcome of 20 Prospectively Followed Pregnancies. |
| Zignego Anna Linda | Lymphoma Prevalence in Patients with Serum Cryoglobulins with or without Cryoglobulinemic Vasculitis: Data Extrapolated From the Cryoglobulinemic Vasculitis Classification Criteria Database. |
| Zijlstra IJsbrand A.J. | Investigating the Cellular Composition of Lymph Nodes in Preclinical and Early Inflammatory Arthritis: A Feasibility Study. |
| Zilberstein Moshe | Long-Term Safety of Tocilizumab in Rheumatoid Arthritis Clinical Trials. |
| Zimmerman Jacquelyn | Transforming Growth Factor- Receptor One Variant Is Associated with Constitutively Decreased Transforming Growth Factor- Signaling and Risk for Systemic Sclerosis. |
| Zimmerman Robert | Cognitive Dysfunction and Diffusion Tensor Imaging in Systemic Lupus Erythematosus. |
| Zimmerman Stefan | Measuring Vascular Burden in Scleroderma and Raynaud Phenomenon. |
| Zimmermann Birgit | CD15s Expression Pattern in the Synovial Tissue of Patients with Rheumatoid Arthritis and Its Role in RASF Migration. |
| Zinchenko Natalia | Calcium Mineral Deposition In the Cultures of Fibroblast-Like Synoviocytes. |
| Zink Angela | Increased Ability to Meet Occupational, Home or Leisure Requirements in Patients Starting Biologic Agents. |
| | Performance of the New ACR/EULAR Remission Criteria Compared to DAS28 Remission in Unselected Real-Life Patients with Rheumatoid Arthritis. |
| | Impact of Different Biologic Agents on the Improvement of Fatigue. |
| | Patients with Rheumatoid Arthritis Who Are in Remission According to the New ACR/EULAR Criteria Have a Very High Functional Capacity Which Is Comparable to Healthy Subjects. |
| | Current Smoking and Hypertension Are Associated with Synovitis As Measured by Ultrasonography in Therapy-Naive Patients with Recent Onset Arthritis: Results from an Early Arthritis Cohort. |
| | Fatigue and Morning Stiffness Are Correlated in Early Arthritis and Both Are Substantially Improved by Glucocorticoids. |
| Zinovieva Elena | Family-Based Association Study of SPA3, a New Susceptibility Locus for Spondyloarthritis on 6p11-q11. |
| Zinsmeister Alan R. | Incidence of Spondyloarthropathy In Patients with Crohn's Disease: A Population-Based Study. |
| Zirkzee E. | The Leiden Neuropsychiatric Systemic Lupus Erythematosus Clinic; Establishing Clinical Phenotypes. |
| Zisman Devy | Increased Prevalence of Metabolic Syndrome and Higher Serum Leptin Levels in Patients with Psoriatic Arthritis. |
| Ziswiler Hans Rudolf | Subclinical Peripheral Synovitis Detected by ultrasound In Patients with Axial Spondyloarthritis. |
| Zizzo Gaetano | The Key Apoptotic Cell Receptor Mer and Its Ligand Gas6 Are Differentially Regulated in M2 Macrophage Subsets. |
| Zlotogorski Zlotogorski | A Novel Autoinflammatory Syndrome Presenting with Chronic Atypical Neutrophilic Dermatitis, Lipodystrophy and Elevated Temperatures (CANDLE syndrome) Caused by Mutation in the Immunoproteasome. |
| Zong Mei | Persisting CD28null T Cells, but Not Regulatory T Cells, in Muscle Tissue of Myositis Patients After Immunosuppressive Therapy. |
| Zou Hejian | Resveratrol Deacetylating Rela/p65 Contributes to Inhibit Transforming Growth Factor-Alpha Induced Inflammation Via a Sirt1 Dependent Manner. |
| | All-Trans Retinoic Acid Sustains the Stability and Function of Natural Regulatory T Cells From Human and Patients with SLE. |
| | Therapeutic Effects of TGF--Induced Regulatory T Cells on the Established Autoimmune Diseases. |
| | Decreased Interleukin-22 in Pulmonary Fibrosis: Potential Role As a Regulatory Cytokine. |
| Zou Qinghua | The Resting State and Task Based Functional Magnetic Resonance Imaging Study in Non-Neuropsychiatric Systemic Lupus Erythematosus. |
| Zouboulis Christos C. | Gender-Specific Differences in Adamantiades-Behet's Disease Presentation and Their Relationship withHLA-B5: An Analysis of 731 Subjects From the German Registry for Adamantiades-Behet's Disease. |
| Zubarev Roman | Identification of Shared Citrullinated Potentially Immunological Targets in the Lungs and Joints of Patients with Rheumatoid Arthritis. |
| Zubler Veronika | Diagnostic Utility of Sacroiliac Joint MRI in Non-Radiographic Spondyloarthritis: Validation of Three Assessment Methods in Two Inception Cohorts. |
| Zufferey Pascal | Subclinical Peripheral Synovitis Detected by ultrasound In Patients with Axial Spondyloarthritis. |
| Zuily Stephane | Thrombin Generation Indicates An Increased Risk for Thromboembolic Events in Lupus and Antiphospholipid Patients. A Prospective Cohort Study. |
| Zuipa Eva-Maria | Prevalence of Psoriatic Arthritis in Dermatological Patients with Psoriasis. |
| Zulian Francesco | Juvenile Idiopathic Arthritis (Jia) Affected Sibling Pairs Present High Correlation for ANA and ILAR Category. |
| | Use of Canakinumab in the Routinary Clinical Practice in Severe Cryopyrin-Associated Periodic Syndrome: One Year of Follow-up. |
| | Long-Term Methotrexate Efficacy in Juvenile Localized Scleroderma. |
| | Recurrent Arthritis As the Sole Presenting Manifestation of Hereditary Autoinflammatory Syndromes. |
| | Impact of MEFV Mutations in Caucasian Children with Periodic Fevers: Clinical Evidence for a Gain of Function Effect. |
| Zvi Ilan Ben | Low Levels of Vitamin-D are Associated with Neuropathy and Lymphoma Among Patients with Sjgren's Syndrome. |
| Zwerina Jochen | Risk of Infections In Rheumatoid Arthritis Patients Treated with Tocilizumaba Retrospective Data-Analysis. |
| | IgG4 Immune Response in Churg-Strauss Syndrome. |
| | Transforming Growth Factor Beta Mediated Activation of Canonical Wnt Signaling Is Crucial for the Development of Fibrosis In Systemic Sclerosis. |
| | Inhibition of Glycogen Synthase Kinase 3 Induces Dermal Fibrosis by Activation of the Canonical Wnt Pathway. |
| | MAPK-Activated Protein Kinase-2 (MK2) Regulates Bone Homeostasis. |
| | Comparative Analysis of Bone Erosions and Cysts in Rheumatoid Arthritis, Psoriatic Arthritis and Erosive Hand Osteoarthritis. |
| Zwillich S. H. | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, As Monotherapy in Japanese Patients with Active Rheumatoid Arthritis: A 12-Week Phase 2b Study. |
| | Tofacitinib (CP-690,550) in Combination with Traditional Disease-Modifying Anti-Rheumatic Drugs: Phase 3 Study Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis and An Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs. |
| | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: a 24-Month Phase 3 Study. |
| | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, As Monotherapy in Patients with Active Rheumatoid Arthritis: A Comparison Between Japanese and Global Populations Over 12 Weeks of Dosing in Phase 2b Studies. |
| | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, As Monotherapy or with Background Methotrexate in Japanese Patients with Rheumatoid Arthritis: A Phase 2/3 Long-Term Extension Study. |
| | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Open-Label, Long-Term Extension Studies up to 36 Months. |
| | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, or Adalimumab Versus Placebo in Patients with Rheumatoid Arthritis on Background Methotrexate: A Phase 3 Study. |
| | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor: Analysis of Infections and All-Cause Mortality Across Phase 3 and Long-Term Extension Studies in Patients with Rheumatoid Arthritis. |
| | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, in Combination with Methotrexate, in Patients with Active Rheumatoid Arthritis with An Inadequate Response to Tumor Necrosis Factor-Inhibitors: A 6-Month Phase 3 Study. |
